Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

AMBS having patents on 47 Protein Biomarkers for Neurodegenerative Diseases including PD. you can see the connection right?


With the acquisition of these assets, Amarantus added following issued patents to its portfolio:

12/802,630 – Diagnosis of Parkinson’s Disease
13/118,175 – Assays for diagnosis and therapeutics…ALS and Parkinson’s Disease
12/069,807 – 47 Protein Biomarkers for Neurodegenerative Diseases
12/804,868 – Assays for Amyotrophic Lateral Sclerosis (ALS) and ALS-like disorders
13/153,669 – Diagnosis of Alzheimer’s Disease

http://www.redorbit.com/news/health/1112754065/amarantus-bioscience-acquires-neurodegenerative-diagnostic-intellectual-property-portfolio-from-power3/